Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer

Published:2017-09-23 Issue:50 Volume:8 Page:87837-87847
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jacob Havjin¹,Stanisavljevic Luka²,Eeg Storli Kristian³,Hestetun Kjersti E.¹,Dahl Olav¹²,Myklebust Mette P.²

Affiliation:

1. Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway

2. Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway

3. Department of Surgery, Haraldsplass Deaconess Hospital, Bergen, Norway

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients;Frontiers in Oncology;2023-11-29

2. miR-23a-3p promotes the development of colon cancer by inhibiting the expression of NDRG4;Clinical and Translational Oncology;2022-11-14

3. Stage-dependent prognostic shift in mismatch repair-deficient tumors: Assessing patient outcomes in stage II and III colon cancer;Frontiers in Oncology;2022-08-30

4. A microRNA panel that regulates proinflammatory cytokines as diagnostic and prognosis biomarkers in colon cancer;Biochemistry and Biophysics Reports;2022-07

5. Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects;Biomedicines;2022-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP